DrugChatter is an AI-powered drug information and brand intelligence platform that shows how generative AI systems understand, describe, compare, and recommend pharmaceutical products.
Patients, caregivers, healthcare professionals, and other audiences increasingly use AI assistants to research medicines. DrugChatter helps pharmaceutical companies understand what those systems say about their brands—and where important information may be missing, inaccurate, outdated, or overshadowed by competitors.
For pharma brand teams, Medical Affairs, Medical Information, Commercial, Digital Marketing, Competitive Intelligence, Regulatory, and Corporate Communications, DrugChatter provides a practical way to monitor and improve visibility in the emerging AI search environment.
The platform can analyze questions people ask about drugs, including questions about indications, efficacy, safety, side effects, dosing, alternatives, competitors, cost, access, and treatment comparisons. It can then evaluate how AI-generated answers represent a brand and identify the sources and information that influence those answers.
DrugChatter is designed for the shift from traditional search-engine optimization to AI visibility and answer-engine optimization. A pharmaceutical website can rank highly in Google while still having limited influence over the answer a patient or healthcare professional receives from an AI system. DrugChatter makes that gap measurable.
Key capabilities
AI Brand Visibility Monitoring — Track how AI systems describe pharmaceutical brands and products.
Question-Level Monitoring — Evaluate the questions that matter to patients, healthcare professionals, and other audiences.
Competitive Intelligence — Compare how a brand is represented against competing therapies.
Answer Accuracy Analysis — Identify potentially incomplete, inaccurate, or outdated information in AI-generated answers.
Source Intelligence — Understand which websites, publications, labels, and other sources contribute to AI answers.
Brand Response Analysis — Examine how AI responds to questions about a specific pharmaceutical product.
AI Search Optimization — Identify opportunities to improve the information ecosystem surrounding a brand so authoritative information is more likely to influence AI-generated answers.
Ongoing Monitoring — Track changes in AI-generated brand representation over time.
DrugChatter is built specifically for the pharmaceutical industry, combining drug intelligence, pharmaceutical information, competitive analysis, and generative-AI monitoring in one platform.
DrugChatter answers a new question for pharmaceutical companies: What does AI say about our drug—and what can we do about it?
